Totals
- Total revenue
- $749,958
- Total expenses
- $1,383,306
- Contributions and grants received
- $742,858
- Grants paid
- $605,000
- Program service revenue
- $0
- Investment income
- $7,100
- Other revenue
- $0
- Total assets, end of year
- $6,110,939
- Total liabilities, end of year
- $14,016
- Net assets or fund balances, end of year
- $6,096,923
- Program services expenses (Part IX)
- $987,430
- Management and general expenses
- $117,577
- Fundraising expenses
- $278,299
- Program service expenses (Part III)
- $987,430
Program services were 71.4% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1f · All other contributions, gifts and grants
$742,858
-
3 · Investment income
total $7,100 · excluded $7,100
Functional expenses
Part IX, the statement of functional expenses.
-
1 · Grants to domestic organizations and governments
total $605,000 · program services $605,000
-
5 · Compensation of officers, directors and key employees
total $193,545 · program services $193,545
-
7 · Other salaries and wages
total $164,353 · program services $69,000 · fundraising $95,353
-
8 · Pension plan contributions
total $4,227 · program services $1,844 · fundraising $2,383
-
9 · Other employee benefits
total $10,476 · program services $1,811 · fundraising $8,665
-
10 · Payroll taxes
total $12,537 · program services $5,279 · fundraising $7,258
-
11a · Fees: management
total $73,500 · program services $73,500
-
11b · Fees: legal
total $4,362 · program services $4,362
-
11c · Fees: accounting
total $8,994 · management and general $8,994
-
12 · Advertising and promotion
total $209,585 · management and general $72,348 · fundraising $137,237
-
13 · Office expenses
total $34,354 · management and general $18,681 · fundraising $15,673
-
14 · Information technology
total $11,156 · management and general $3,885 · fundraising $7,271
-
17 · Travel
total $3,474 · management and general $1,648 · fundraising $1,826
-
19 · Conferences, conventions and meetings
total $32,995 · program services $32,995
-
23 · Insurance
total $4,227 · management and general $3,639 · fundraising $588
-
24a · Other expenses: DUES AND MEMBERSHIPS
total $10,465 · program services $38 · management and general $8,382 · fundraising $2,045
-
24b · Other expenses: OTHER EXPENSES
total $56 · program services $56
Balance sheet
Part X, book values.
-
1 · Cash, non-interest-bearing
beginning of year $228,387 · end of year $477,957
-
2 · Savings and temporary cash investments
beginning of year $1,826,504 · end of year $2,975,000
-
3 · Pledges and grants receivable
beginning of year $4,690,880 · end of year $2,657,982
-
17 · Accounts payable and accrued expenses
beginning of year $15,500 · end of year $14,016
-
29 · Capital stock, trust principal or current funds
beginning of year $0 · end of year $0
-
30 · Paid-in or capital surplus, or land, building or equipment fund
beginning of year $0 · end of year $0
-
31 · Retained earnings, endowment or other funds
beginning of year $6,730,271 · end of year $6,096,923
Mission and programs · 2022
Mission
THE OSTEOSARCOMA INSTITUTE WILL DEVELOP AND EXECUTE A COMPREHENSIVE, RATIONAL STRATEGY TO DRAMATICALLY IMPROVE THE LIFE EXPECTANCY OF RELAPSED AND METASTATIC OSTEOSARCOMA PATIENTS.
-
THE OSTEOSARCOMA INSTITUTE EXECUTED AGREEMENTS TO FUND GRANTS FOR A TOTAL OF $404,411 TRANSLATIONAL SCIENCE GRANT AGREEMENTS WITH THE UNIVERSITY OF MINNESOTA. $200,000 OF THIS WAS FUNDED IN 2022.
Expenses $200,000 · Grants $200,000
-
THE OSTEOSARCOMA INSTITUTE EXECUTED AGREEMENTS TO FUND GRANTS FOR A TOTAL OF $560,000 PRECLINICAL AND TRANSLATIONAL SCIENCE GRANT AGREEMENTS WITH UNIVERSITY OF CALIFORNIA, SAN FRANCISCO. $185,000 OF THIS WAS FUNDED IN 2022.
Expenses $185,000 · Grants $185,000
-
THE OSTEOSARCOMA INSTITUTE EXECUTED AGREEMENTS TO FUND TWO GRANTS FOR A TOTAL OF $1,300,000 FOR A CLINICAL TRIAL AND CORRELATIVE STUDY WITH THE DANA FARBER CANCER INSTITUTE. $165,000 OF THIS WAS FUNDED IN 2022.
Expenses $165,000 · Grants $165,000
-
THE OSTEOSARCOMA INSTITUTE EXECUTED AGREEMENTS TO FUND GRANTS FOR A TOTAL OF $700,000 FOR CLINICAL TRIAL AND TRANSLATIONAL SCIENCE GRANT AGREEMENTS WITH THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER. $55,000 OF THIS WAS FUNDED IN 2022.
Expenses $437,430 · Grants $55,000
As filed on the 2022 return. The filer continues this part on Schedule O, which is not shown here.
Listed in Part VII
-
Lee HelmanLEE HELMAN
INSTITUTE DIRECTOR
- Total calculated
- $193,545
- From this org
- $193,545
- From related orgs
- $0
- Other
- $0
- Hours/week
- 16
Schedule J breakdown matched by us
- Base
- $193,545
- Bonus
- $0
- Other
- $0
- Deferred
- $0
- Nontaxable benefits
- $0
- Filer's total
- $193,545
-
McHenry Tichenor JrMCHENRY TICHENOR JR
CHAIR OF BOARD OF TRUSTEES
- Total calculated
- $0
- Hours/week
- 40
-
Mary Katherine ClarkeMARY KATHERINE CLARKE
BOARD OF TRUSTEES
- Total calculated
- $0
- Hours/week
- 2
-
Lisa TichenorLISA TICHENOR
BOARD OF TRUSTEES
- Total calculated
- $0
- Hours/week
- 2
-
Bret AlexanderBRET ALEXANDER
FORMER CHAIR OF BOARD OF TRUSTEES
- Total calculated
- $0
- Hours/week
- 2
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.
Schedule J
Answered yes
- 3 · Approval by the board or compensation committee
Answered no
- 4a · Severance or change-of-control payment
- 4b · Supplemental nonqualified retirement plan
- 4c · Equity-based compensation arrangement
- 5a · Pay contingent on this organization's revenues
- 5b · Pay contingent on a related organization's revenues
- 6a · Pay contingent on this organization's net earnings
- 6b · Pay contingent on a related organization's net earnings
- 7 · Other non-fixed payments
- 8 · Paid under the initial-contract exception
Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.
Grants on this return
-
TRANSLATIONAL RESEARCH GRANT
-
TRANSLATIONAL RESEARCH GRANTS
-
$165,000
CLINICAL TRIAL AND CORRELATIVE RESEARCH GRANTS
-
THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER
$55,000
CLINICAL TRIAL GRANT
Provenance
- Return type
- form_990
- Tax year
- 2022
- Filed
- 10 November 2023
- IRS schema version
- 2022v5.0
- Source object
- 202313149349304391
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.